Potential and challenges of induced pluripotent stem cells in liver diseases treatment

Journal of Clinical Medicine

Volumn 3, Issue 3, 2014, Pages 997-1017

  Yu, Yue ^a,b   Wang, Xuehao ^a,b   Nyberg, Scott L ^c  

^a BEIJING HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Mayo Clinic College of Medicine   (United States)

Author keywords

Animal model; Hepatic differentiation; iPSCs; Liver disease

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; GREEN FLUORESCENT PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4; LOW DENSITY LIPOPROTEIN;

BIOARTIFICIAL LIVER; CELL DIFFERENTIATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; EMBRYONIC STEM CELL; ENGRAFTMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HEPATIC PROGENITOR CELL; HEPATOCYTE TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER FIBROSIS; LIVER REGENERATION; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW;

EID: 85048840746     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm3030997     Document Type: Review

References (71)

1. Dianat, N.; Steichen, C.; Vallier, L.; Weber, A.; Dubart-Kupperschmitt, A. Human pluripotent stem cells for modelling human liver diseases and cell therapy. Curr. Gene Ther. 2013, 13, 120-132.
2. Terry, C.; Dhawan, A.; Mitry, R.R.; Lehec, S.C.; Hughes, R.D. Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl. 2010, 16, 229-237.
3. Yu, Y.; Hongling, L.; Ikeda, Y.; Amiot, B.; Rinaldo, P.; Duncan, S.; Nyberg, S. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies. Stem Cell Res. 2012, 9, 196-207.
4. Si-Tayeb, K.; Noto, F.K.; Nagaoka, M.; Li, J.; Battle, M.A.; Duris, C.; North, P.E.; Dalton, S.; Duncan, S.A. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51, 297-305.
5. Rashid, S.T.; Corbineau, S.; Hannan, N.; Marciniak, S.J.; Miranda, E.; Alexander, G.; Huang-Doran, I.; Griffin, J.; Ahrlund-Richter, L.; Skepper, J., et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Investig. 2010, 120, 3127-3136.
6. Song, Z.; Cai, J.; Liu, Y.; Zhao, D.; Yong, J.; Duo, S.; Song, X.; Guo, Y.; Zhao, Y.; Qin, H., et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009, 19, 1233-1242.
7. Asgari, S.; Pournasr, B.; Salekdeh, G.H.; Ghodsizadeh, A.; Ott, M.; Baharvand, H. Induced pluripotent stem cells: A new era for hepatology. J. Hepatol. 2010, 53, 738-751.
8. Zhang, Q.; Yang, Y.; Zhang, J.; Wang, G.Y.; Liu, W.; Qiu, D.B.; Hei, Z.Q.; Ying, Q.L.; Chen, G.H. Efficient derivation of functional hepatocytes from mouse induced pluripotent stem cells by a combination of cytokines and sodium butyrate. Chin. Med. J. 2011, 124, 3786-3793.
9. Takayama, K.; Inamura, M.; Kawabata, K.; Katayama, K.; Higuchi, M.; Tashiro, K.; Nonaka, A.; Sakurai, F.; Hayakawa, T.; Furue, M.K., et al. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. Mol. Ther. 2012, 20, 127-137.
10. Chen, Y.F.; Tseng, C.Y.; Wang, H.W.; Kuo, H.C.; Yang, V.W.; Lee, O.K. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 2011, 55, 1193-1203.
11. Espejel, S.; Roll, G.R.; McLaughlin, K.J.; Lee, A.Y.; Zhang, J.Y.; Laird, D.J.; Okita, K.; Yamanaka, S.; Willenbring, H. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J. Clin. Investig. 2010, 120, 3120-3126.
12. Asgari, S.; Moslem, M.; Bagheri-Lankarani, K.; Pournasr, B.; Miryounesi, M.; Baharvand, H. Differentiation and Transplantation of Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells. Stem Cell Rev. 2013, 9, 493-504.
13. Choi, S.M.; Kim, Y.; Liu, H.; Chaudhari, P.; Ye, Z.; Jang, Y.Y. Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle 2011, 10, 2423-2427.
14. Iwamuro, M.; Shiraha, H.; Nakaji, S.; Furutani, M.; Kobayashi, N.; Takaki, A.; Yamamoto, K. A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes. Biomed. Eng. Online 2012, 11, doi:10.1186/1475-925X-11-93.
15. Yusa, K.; Rashid, S.T.; Strick-Marchand, H.; Varela, I.; Liu, P.Q.; Paschon, D.E.; Miranda, E.; Ordonez, A.; Hannan, N.R.; Rouhani, F.J., et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011, 478, 391-394.
16. Zhang, S.; Chen, S.; Li, W.; Guo, X.; Zhao, P.; Xu, J.; Chen, Y.; Pan, Q.; Liu, X.; Zychlinski, D., et al. Rescue of ATP7B function in hepatocyte-like cells from Wilson’s disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum. Mol. Genet. 2011, 20, 3176-3187.
17. Zhou, X.L.; Sullivan, G.J.; Sun, P.; Park, I.H. Humanized murine model for HBV and HCV using human induced pluripotent stem cells. Arch. Pharm. Res. 2012, 35, 261-269.
18. Yoshida, T.; Takayama, K.; Kondoh, M.; Sakurai, F.; Tani, H.; Sakamoto, N.; Matsuura, Y.; Mizuguchi, H.; Yagi, K. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem. Biophys. Res. Commun. 2011, 416, 119-124.
19. Schwartz, R.E.; Trehan, K.; Andrus, L.; Sheahan, T.P.; Ploss, A.; Duncan, S.A.; Rice, C.M.; Bhatia, S.N. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 2012, 109, 2544-2548.
20. Ghodsizadeh, A.; Taei, A.; Totonchi, M.; Seifinejad, A.; Gourabi, H.; Pournasr, B.; Aghdami, N.; Malekzadeh, R.; Almadani, N.; Salekdeh, G.H., et al. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev. 2010, 6, 622-632.
21. Medine, C.N.; Lucendo-Villarin, B.; Storck, C.; Wang, F.; Szkolnicka, D.; Khan, F.; Pernagallo, S.; Black, J.R.; Marriage, H.M.; Ross, J.A., et al. Developing high-fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Transl. Med. 2013, 2, 505-509.
22. Baxter, M.A.; Rowe, C.; Alder, J.; Harrison, S.; Hanley, K.P.; Park, B.K.; Kitteringham, N.R.; Goldring, C.E.; Hanley, N.A. Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res. 2010, 5, 4-22.
23. Choi, S.M.; Kim, Y.; Shim, J.S.; Park, J.T.; Wang, R.H.; Leach, S.D.; Liu, J.O.; Deng, C.; Ye, Z.; Jang, Y.Y. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 2013, 57, 2458-2468.
24. Prescott, C. The business of exploiting induced pluripotent stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366, 2323-2328.
25. Zuba-Surma, E.K.; Wojakowski, W.; Madeja, Z.; Ratajczak, M.Z. Stem cells as a novel tool for drug screening and treatment of degenerative diseases. Curr. Pharm. Des. 2012, 18, 2644-2656.
26. Nyberg, S.L. Bridging the gap: Advances in artificial liver support. Liver Transpl. 2012, 18, doi:10.1002/lt.23506.
27. LeCluyse, E.L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur. J. Pharm. Sci. 2001, 13, 343-368.
28. Goldring, C.E.; Kitteringham, N.R.; Jenkins, R.; Lovatt, C.A.; Randle, L.E.; Abdullah, A.; Owen, A.; Liu, X.; Butler, P.J.; Williams, D.P., et al. Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes. Am. J. Physiol. Cell Physiol. 2006, 290, C104-C115.
29. Soto-Gutierrez, A.; Kobayashi, N.; Rivas-Carrillo, J.D.; Navarro-Alvarez, N.; Zhao, D.; Okitsu, T.; Noguchi, H.; Basma, H.; Tabata, Y.; Chen, Y., et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat. Biotechnol. 2006, 24, 1412-1419.
30. Fox, I.J.; Chowdhury, J.R.; Kaufman, S.S.; Goertzen, T.C.; Chowdhury, N.R.; Warkentin, P.I.; Dorko, K.; Sauter, B.V.; Strom, S.C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 1998, 338, 1422-1426.
31. Simara, P.; Motl, J.A.; Kaufman, D.S. Pluripotent stem cells and gene therapy. Transl. Res. 2013, 161, 284-292.
32. Garate, Z.; Davis, B.R.; Quintana-Bustamante, O.; Segovia, J.C. New frontier in regenerative medicine: Site-specific gene correction in patient-specific induced pluripotent stem cells. Hum. Gene Ther. 2013, 24, 571-583.
33. Ala, A.; Walker, A.P.; Ashkan, K.; Dooley, J.S.; Schilsky, M.L. Wilson’s disease. Lancet 2007, 369, 397-408.
34. Raya, A.; Rodriguez-Piza, I.; Navarro, S.; Richaud-Patin, Y.; Guenechea, G.; Sanchez-Danes, A.; Consiglio, A.; Bueren, J.; Belmonte, J.C.I. A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat. Protoc. 2010, 5, 647-660.
35. Ordonez, M.P.; Goldstein, L.S. Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver. Semin. Liver Dis. 2012, 32, 298-306.
36. Hickey, R.D.; Mao, S.A.; Glorioso, J.; Lillegard, J.B.; Fisher, J.E.; Amiot, B.; Rinaldo, P.; Harding, C.O.; Marler, R.; Finegold, M.J., et al. Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res. 2014, 13, 144-153.
37. Lee, K.; Kwon, D.N.; Ezashi, T.; Choi, Y.J.; Park, C.; Ericsson, A.C.; Brown, A.N.; Samuel, M.S.; Park, K.W.; Walters, E.M., et al. Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc. Natl. Acad. Sci. USA 2014, 111, 7260-7265.
38. Park, I.H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A.; Lensch, M.W.; Cowan, C.; Hochedlinger, K.; Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134, 877-886.
39. Shafa, M.; Sjonnesen, K.; Yamashita, A.; Liu, S.; Michalak, M.; Kallos, M.S.; Rancourt, D.E. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J. Tissue Eng. Regen. Med. 2012, 6, 462-472.
40. Kehoe, D.E.; Jing, D.; Lock, L.T.; Tzanakakis, E.S. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. Part A 2010, 16, 405-421.
41. Chen, A.K.; Reuveny, S.; Oh, S.K. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future direction. Biotechnol. Adv. 2013, 31, 1032-1046.
42. Yi, F.; Liu, G.H.; Belmonte, J.C.I. Human induced pluripotent stem cells derived hepatocytes: Rising promise for disease modeling, drug development and cell therapy. Protein Cell 2012, 3, 246-250.
43. Ogawa, S.; Surapisitchat, J.; Virtanen, C.; Ogawa, M.; Niapour, M.; Sugamori, K.S.; Wang, S.; Tamblyn, L.; Guillemette, C.; Hoffmann, E., et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 2013, 140, 3285-3296.
44. Shan, J.; Schwartz, R.E.; Ross, N.T.; Logan, D.J.; Thomas, D.; Duncan, S.A.; North, T.E.; Goessling, W.; Carpenter, A.E.; Bhatia, S.N. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat. Chem. Biol. 2013, 9, 514-520.
45. Huang, P.; He, Z.; Ji, S.; Sun, H.; Xiang, D.; Liu, C.; Hu, Y.; Wang, X.; Hui, L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475, 386-389.
46. Hentze, H.; Soong, P.L.; Wang, S.T.; Phillips, B.W.; Putti, T.C.; Dunn, N.R. Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res. 2009, 2, 198-210.
47. Hedlund, E.; Pruszak, J.; Ferree, A.; Vinuela, A.; Hong, S.; Isacson, O.; Kim, K.S. Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations. Stem Cells 2007, 25, 1126-1135.
48. Basma, H.; Soto-Gutierrez, A.; Yannam, G.R.; Liu, L.; Ito, R.; Yamamoto, T.; Ellis, E.; Carson, S.D.; Sato, S.; Chen, Y., et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136, 990-999.
49. Schmelzer, E.; Zhang, L.; Bruce, A.; Wauthier, E.; Ludlow, J.; Yao, H.L.; Moss, N.; Melhem, A.; McClelland, R.; Turner, W., et al. Human hepatic stem cells from fetal and postnatal donors. J. Exp. Med. 2007, 204, 1973-1987.
50. Lu, T.Y.; Lu, R.M.; Liao, M.Y.; Yu, J.; Chung, C.H.; Kao, C.F.; Wu, H.C. Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells. J. Biol. Chem. 2010, 285, 8719-8732.
51. Yamashita, T.; Ji, J.; Budhu, A.; Forgues, M.; Yang, W.; Wang, H.Y.; Jia, H.; Ye, Q.; Qin, L.X.; Wauthier, E., et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136, 1012-1024.
52. Yang, G.; Si-Tayeb, K.; Corbineau, S.; Vernet, R.; Gayon, R.; Dianat, N.; Martinet, C.; Clay, D.; Goulinet-Mainot, S.; Tachdjian, G., et al. Integration-deficient lentivectors: An effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors. BMC Biol. 2013, 11, 86.
53. Rhim, J.A.; Sandgren, E.P.; Palmiter, R.D.; Brinster, R.L. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc. Natl. Acad. Sci. USA 1995, 92, 4942-4946.
54. Meuleman, P.; Libbrecht, L.; de Vos, R.; de Hemptinne, B.; Gevaert, K.; Vandekerckhove, J.; Roskams, T.; Leroux-Roels, G. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 2005, 41, 847-856.
55. Azuma, H.; Paulk, N.; Ranade, A.; Dorrell, C.; Al-Dhalimy, M.; Ellis, E.; Strom, S.; Kay, M.A.; Finegold, M.; Grompe, M. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice. Nat. Biotechnol. 2007, 25, 903-910.
56. Murry, C.E.; Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008, 132, 661-680.
57. Yanagida, A.; Ito, K.; Chikada, H.; Nakauchi, H.; Kamiya, A. An In Vitro Expansion System for Generation of Human iPS Cell-Derived Hepatic Progenitor-Like Cells Exhibiting a Bipotent Differentiation Potential. PLoS One 2013, 8, e67541.
58. Cheng, X.; Ying, L.; Lu, L.; Galvao, A.M.; Mills, J.A.; Lin, H.C.; Kotton, D.N.; Shen, S.S.; Nostro, M.C.; Choi, J.K., et al. Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 2012, 10, 371-384.
59. Vosough, M.; Omidinia, E.; Kadivar, M.; Shokrgozar, M.A.; Pournasr, B.; Aghdami, N.; Baharvand, H. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev. 2013, 22, 2693-2705.
60. Matsumoto, K.; Yoshitomi, H.; Rossant, J.; Zaret, K.S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294, 559-563.
61. Konstantinova, I.; Lammert, E. Microvascular development: Learning from pancreatic islets. Bioessays 2004, 26, 1069-1075.
62. Hammar, E.; Parnaud, G.; Bosco, D.; Perriraz, N.; Maedler, K.; Donath, M.; Rouiller, D.G.; Halban, P.A. Extracellular matrix protects pancreatic beta-cells against apoptosis: Role of short-and long-term signaling pathways. Diabetes 2004, 53, 2034-2041.
63. Snykers, S.; de Kock, J.; Rogiers, V.; Vanhaecke, T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: State of the art. Stem Cells 2009, 27, 577-605.
64. Flaim, C.J.; Chien, S.; Bhatia, S.N. An extracellular matrix microarray for probing cellular differentiation. Nat. Methods 2005, 2, 119-125.
65. Hannan, N.R.; Segeritz, C.P.; Touboul, T.; Vallier, L. Production of hepatocyte-like cells from human pluripotent stem cells. Nat. Protoc. 2013, 8, 430-437.
66. Zhao, X.Y.; Lv, Z.; Li, W.; Zeng, F.; Zhou, Q. Production of mice using iPS cells and tetraploid complementation. Nat. Protoc. 2010, 5, 963-971.
67. Takebe, T.; Sekine, K.; Enomura, M.; Koike, H.; Kimura, M.; Ogaeri, T.; Zhang, R.R.; Ueno, Y.; Zheng, Y.W.; Koike, N., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013, 499, 481-484.
68. Chan, C.C.; Cheng, L.Y.; Lu, J.; Huang, Y.H.; Chiou, S.H.; Tsai, P.H.; Huo, T.I.; Lin, H.C.; Lee, F.Y. The role of interferon-gamma inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation. PLoS One 2012, 7, e50577.
69. Hickey, R.D.; Lillegard, J.B.; Fisher, J.E.; McKenzie, T.J.; Hofherr, S.E.; Finegold, M.J.; Nyberg, S.L.; Grompe, M. Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer. Hepatology 2011, 54, 1351-1359.
70. Zhao, T.; Zhang, Z.N.; Rong, Z.; Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474, 212-215.
71. Uygun, B.E.; Yarmush, M.L.; Uygun, K. Application of whole-organ tissue engineering in hepatology. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 738-744.